Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538
- Citation:
- Lung Cancer vol 156 68-71
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 10
- Parents:
- 3127
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, UG1CA233253, UG1CA233324, UG1CA233327, UG1CA233329, U10CA180868 (RTOG/NRG)
- Corr. Author:
- Authors:
- Jeffrey Bogart Xiaofei Wang Gregory Masters Junheng Gao Ritsuko Komaki Laurie E. Gaspar John Heymach Michael Christian Dobelbower Charles Kuzma Tom Stinchcombe Everett Vokes
- Networks:
- CHRISTIANA, CO015, LAPS-IL057, LAPS-NC010, LAPS-TX035, NY141, SCOR
- Study
- CALGB-30610
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- small cell, radiotherapy dose, fractionation